FDA declines to approve Agile's contraceptive patch
(Reuters) - Agile Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve the company's contraceptive patch, citing deficiencies related to its adhesion test methods.
from Reuters: Health News http://reut.rs/2Bm5vAC
http://bit.ly/2zwRqiM